🇮🇪Ireland
16°C Partly Cloudy · Dublin
Live Updates
--:--:-- IST
Writer Login
Latest
Clinical Trials in the USA / NCT06146049
Starting soon Observational

Exploring Clinical Study Experiences of People With Post Traumatic Stress Disorder

NCT06146049 · tracked via the Priya Life Science USA tracker
Sponsor
Power Life Sciences Inc.
Phase
Observational
Started
2024-12
Last updated
2023-11-24

Condition(s) studied

Post Traumatic Stress Disorder

Study summary

Participation in post traumatic stress disorder observational study serves as a crucial contribution to advancing medical knowledge and refining the care provided to individuals facing similar health challenges.

The primary objective centers on a meticulous examination of trial completion rates and voluntary withdrawals within this distinct patient population.

Eligibility

Sex
ALL
Min age
18 Years
Max age
Healthy volunteers
No
Inclusion Criteria: * Diagnosis of post traumatic stress disorder * No prior treatment for post traumatic stress disorder * Willing and able to provide informed consent. Exclusion Criteria: * Enrolled in another research study * Psychiatric or behavioral illness * Inability to provide written informed consent

Primary outcome measure(s)

Trial sites (1)

FacilityCityRegionStatus
Power Life Sciences San Francisco California

More Power Life Sciences Inc. trials in the USA

Other trials for the same condition

Official registry record

This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.

View NCT06146049 on ClinicalTrials.gov ↗ ← All trials in the USA